HomeBBIO • NASDAQ
add
BridgeBio Pharma Inc
Previous close
$52.60
Day range
$51.03 - $54.29
Year range
$21.72 - $54.60
Market cap
9.79B USD
Avg Volume
2.84M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 110.56M | 4,999.86% |
Operating expense | 240.38M | 37.98% |
Net income | -181.90M | -147.64% |
Net profit margin | -164.52 | 95.14% |
Earnings per share | -0.95 | 5.62% |
EBITDA | -132.16M | 22.75% |
Effective tax rate | -1.16% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 756.89M | 69.04% |
Total assets | 1.08B | 35.98% |
Total liabilities | 2.86B | 52.34% |
Total equity | -1.78B | — |
Shares outstanding | 191.17M | — |
Price to book | -5.63 | — |
Return on assets | -34.02% | — |
Return on capital | -222.80% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -181.90M | -147.64% |
Cash from operations | -80.68M | -208.00% |
Cash from investing | -13.00M | -527.84% |
Cash from financing | 302.04M | 5,372.14% |
Net change in cash | 208.36M | 189.33% |
Free cash flow | -50.02M | -268.13% |
About
CEO
Founded
2015
Headquarters
Website
Employees
728
